IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Sai Life Sciences IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ 3042.62 Cr. The company is based in Hyderabad and caters to Chemical sector. Iifl Securities , Jefferies India , Kotak Mahindra Capital Company , Morgan Stanley India Company are the merchant bankers of Sai Life Sciences IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 29th July 2024.
Sai Life Sciences IPO open date is 11th December 2024 and close date is 13th December 2024. IPO Allotment Date is 16th December 2024 and Listing date is 18th December 2024.
IPO
Size:
₹ 3042.62 Cr.
Avg IPO Size (Sector Based)
: ₹
595.38 cr.
Sector: Chemical
IPO so far:
39
Merchant Banker:
Iifl Securities
IPO by BRLM so far:
91
City:
Hyderabad
IPO so far:
36
Revenue (annualised):
₹
1386.70
cr. 
PE
Ratio:
203.82x
Average Sector PE Ratio: 23.14x
Sai Life Sciences IPO size is ₹ 3042.62 Cr. with IPO price of ₹ 549.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Iifl Securities Limited is the book-running lead manager of the Sai Life Sciences IPO. Kfin Technologies Limited is the Registrar for Sai Life Sciences IPO.
Sai Life Sciences IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Sai Life Sciences IPO, based in Hyderabad, operates in the Chemical sector with a focus on offers tailor-made services to biotech firms and global pharma companies.. The company is launching its MainBoard IPO on the BSE,NSE exchange, using the Book Building Issue method. Sai Life Sciences IPO size is ₹ 3042.62 Cr. with fresh issue size of ₹ 950.00 Cr. and Offer for sale being ₹ 2092.62Cr.
The IPO allotment date for Sai Life Sciences IPO is expected to be 16th December 2024, after the finalization of basis of allotment. Investors can check Sai Life Sciences IPO allotment status on the registrars website, Kfin Technologies Limited . Sai Life Sciences IPO refund dates are 17th December 2024.
Sai Life Sciences IPO is expected to be listed on 18th December 2024.
The upper price band for the Sai Life Sciences IPO is set at ₹ 549.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Sai Life Sciences IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Sai Life Sciences IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 13th December 2024. After submission, funds are blocked until the basis of allotment of Sai Life Sciences IPO is finalised.
The merchant banker for Sai Life Sciences IPO is Iifl Securities Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited , Morgan Stanley India Company Private Limited . Iifl Securities Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited , Morgan Stanley India Company Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Sai Life Sciences IPO RHP for further details.
The registrar for Sai Life Sciences IPO is Kfin Technologies Limited . Investors can go to Kfin Technologies Limited registrar website for IPO allotment status, refund processing, and other queries related to Sai Life Sciences IPO through their official website or helpline.
Sai Life Sciences IPO was subscribed 10.27 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 3042.62 Cr.
Avg IPO Size (Sector Based)
:
₹ 595.38 Cr.
Sector: Chemical
IPO so far:
39
Merchant Banker:
Iifl Securities
IPO by BRLM so far:
91
City:
Hyderabad
IPO so far:
36
Revenue (annualised):
₹ 1,350.40 cr.
PE
Ratio:
203.82x
Average Sector PE Ratio: 23.14x
Sai Life Sciences IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Sai Life Sciences Financial Review Page
Merchant Banker(s) of Sai Life Sciences IPO: Iifl Securities Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited , Morgan Stanley India Company Private Limited
Sai Life Sciences IPO subscription was 10.27 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Sai Life Sciences IPO listed at a listing price of 764.65 against the offer price of 549.00.
The current market price of Sai Life Sciences is 749.65.
Why Us?
